Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Nature Medicine2015Vol. 21(9), pp. 1065–1070
Citations Over TimeTop 1% of 2015 papers
Hadi M. Yassine, Jeffrey C. Boyington, Patrick M. McTamney, Chih‐Jen Wei, Masaru Kanekiyo, Wing-Pui Kong, John R. Gallagher, Lingshu Wang, Yi Zhang, Michael Joyce, Daniel Lingwood, Syed M. Moin, Hanné Andersen, Yoshinobu Okuno, Srinivas S. Rao, Audray K. Harris, Peter D. Kwong, John R. Mascola, Gary J. Nabel, Barney S. Graham
Related Papers
- → Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains(2017)564 cited
- → Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine(2005)136 cited
- → Human Immunity and the Design of Multi-Component, Single Target Vaccines(2007)36 cited
- → SPRi-based hemagglutinin quantitative assay for influenza vaccine production monitoring(2019)10 cited
- [Standards of attenuated influenza vaccine].(1982)